What is SimCare AI?
SimCare AI is a specialized healthtech enterprise that develops simulated conversations with AI-powered patients to optimize healthcare training workflows. By enabling clinical simulations that do not require direct human supervision, the company allows healthcare organizations to significantly reduce training costs and time-to-competency. This approach is particularly relevant in the current regulatory environment, where governments are actively seeking to expand the healthcare workforce but are often hindered by the logistical and legal requirements of traditional clinical supervision. SimCare AI serves as a bridge between these regulatory demands and the need for high-volume, high-quality medical education, positioning itself as an essential infrastructure provider for hospitals, nursing schools, and government health agencies.
How much funding has SimCare AI raised?
SimCare AI has raised a total of $2M across 1 funding round:
Angel/Seed
$2M
Angel/Seed (2025): $2M with participation from Asymmetry Ventures, Drive Capital, Goodwater Capital, and Y Combinator
Key Investors in SimCare AI
Asymmetry Ventures
Asymmetry VC is a venture capital firm recognized by Business Insider as one of the world's top early-stage investors. The firm focuses on backing companies that aim to push humanity forward through seed-stage funding.
Drive Capital
Drive Capital is a venture capital firm based in Columbus that invests in exceptional founders creating the next generation of market-defining companies, emphasizing partnerships that drive growth from idea to IPO.
Goodwater Capital
Goodwater Capital is a consumer tech investment firm that empowers exceptional entrepreneurs to create positive change, focusing on innovative companies across sectors including financial services and healthcare.
What's next for SimCare AI?
With this major enterprise-level funding, SimCare AI is poised to accelerate its product development roadmap and expand its market reach. The strategic focus will likely center on enhancing the fidelity of its AI patient models and integrating its platform into broader institutional learning management systems. As the company scales, it will need to navigate the complexities of healthcare accreditation standards while maintaining the high level of clinical accuracy required for medical training. The backing from prominent venture firms suggests a strong trajectory toward becoming a standard-bearer in the digital health education sector, potentially setting the stage for future partnerships with large-scale healthcare providers and academic institutions looking to modernize their training infrastructure.
See full SimCare AI company page
